Intelligent Investor

AdAlta Limited (ASX: 1AD) - Announcements

- Current share price for 1AD : $0.029

ASX company news and announcements for AdAlta Limited (1AD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All AdAlta Limited (1AD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than AdAlta Limited (1AD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for AdAlta Limited (1AD)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$15 Notification of Expiry of Listed Options 24 Apr 2024 12:53PM $0.029 $0.029 $0.027 fallen by 0%
$15 SYNBV MoU Webinar presentation 10 Apr 2024 8:46AM $0.027 $0.029 $0.027 risen by 7.41%
$15 Webinar to discuss SYNthesis BioVentures partnership 8 Apr 2024 9:03AM $0.029 $0.029 $0.027 fallen by 0%
$15 SYNThesis BioVentures MoU for cellular immunotherapies 8 Apr 2024 8:57AM $0.029 $0.029 $0.027 fallen by 0%
$15 AdAlta presenting at ASX Gems conference 20 Mar 2024 8:24AM $0.025 $0.029 $0.027 risen by 16%
$15 Application for quotation of securities - 1AD 15 Mar 2024 11:14AM $0.026 $0.029 $0.027 risen by 11.54%
$15 Corporate Presentation 8 Mar 2024 8:18AM $0.027 $0.029 $0.027 risen by 7.41%
$15 Share Cafe webinar on Phase I results 7 Mar 2024 8:19AM $0.029 $0.029 $0.027 fallen by 0%
$15 Positive AD-214 Phase I extension study results 6 Mar 2024 8:35AM $0.025 $0.029 $0.027 risen by 16%
$15 Half Yearly Report and Accounts 27 Feb 2024 8:09AM $0.022 $0.029 $0.027 risen by 31.82%
$15 Australia Biologics Festival Presentation 20 Feb 2024 8:29AM $0.023 $0.029 $0.027 risen by 26.09%
$15 Quarterly Appendix 4C and Activities Report 31 Jan 2024 9:18AM $0.024 $0.029 $0.027 risen by 20.83%
$15 January 2024 partnering presentations and progress 22 Jan 2024 9:45AM $0.024 $0.029 $0.027 risen by 20.83%
$15 Notification regarding unquoted securities - 1AD 10 Jan 2024 8:19AM $0.025 $0.029 $0.027 risen by 16%
$15 Change of Director's Interest Notice (TO) 20 Dec 2023 8:15AM $0.025 $0.029 $0.027 risen by 16%
$15 New malaria inhibiting i-body 19 Dec 2023 9:03AM $0.024 $0.029 $0.027 risen by 20.83%
$15 Application for quotation of securities - 1AD 19 Dec 2023 8:18AM $0.024 $0.029 $0.027 risen by 20.83%
$15 Application for quotation of securities - 1AD 19 Dec 2023 8:18AM $0.024 $0.029 $0.027 risen by 20.83%
$15 Application for quotation of securities - 1AD 19 Dec 2023 8:18AM $0.024 $0.029 $0.027 risen by 20.83%
$15 Change of Director's Interest Notice x 4 (TO, PM, DF & RP) 19 Dec 2023 8:17AM $0.024 $0.029 $0.027 risen by 20.83%
$15 AdAlta launches new InvestorHub 18 Dec 2023 11:23AM $0.024 $0.029 $0.027 risen by 20.83%
$15 Results of Meeting 14 Dec 2023 1:01PM $0.024 $0.029 $0.027 risen by 20.83%
$15 Chair address to EGM 14 Dec 2023 10:40AM $0.023 $0.029 $0.027 risen by 26.09%
$15 Investor Webinar Presentation 23 Nov 2023 11:46AM $0.019 $0.029 $0.027 risen by 52.63%
$15 Results of Meeting 22 Nov 2023 2:22PM $0.020 $0.029 $0.027 risen by 45%

1 - 25 of 514 results

Page 1 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.